Cookie Consent by PrivacyPolicies.com

November 15, 2021

HUTER project participates in the Medica Düsseldorf 2021 Trade Fair

Date: November 15th -18th 2021


The Innovation Director from BAHIA Software, Sergio Figueiras, will present the last developments achieved within the HUTER project to the industry as part of his attendance to MEDICA 2021, the World Forum for Medicine that this year is taking place in Düsseldorf, Germany.


https://www.medica-tradefair.com/


The Human Uterus Cell Atlas project (HUTER) is focused on creating the cellular reference map of the human uterus.


HUTER partners are advancing the development of a digital cloud platform that will support researchers in processing and analyzing OMICs data. Specifically, the platform, created by the BAHIA team, will collect a large amount of single cell data and metadata, allowing high-throughput analysis over cell sequencing data. The HUTER platform includes open tools to share and visualize not only single cell data, but also images from advanced microscopy techniques. For this, the HUTER platform includes algorithms to transform closed-format image files generated within HUTER into a medical standard format (DICOM) and an advanced DICOM viewer.


About the Human Uterus Cells Atlas – HUTER


The human uterus is a flagship reproductive organ with profound implications not only in reproduction but also in women ́s health. HUTER can advance the Human Cell Atlas initiative for the exploitation potential in Obstetrics and Gynecology and biomedicine research areas such as Regenerative Medicine or Reproductive Medicine.


The uterus is itself a model for regenerative medicine since (i) endometrial tissue regenerates monthly and its transformation is executed through dynamic changes in states and interactions of multiple cell types, and (ii) myometrial tissue has remarkable regenerative capacity and extensive remodelling throughout pregnancy. Hence, the primary motivation HUTER proposal stems from the need to better understand the human uterus in order to more effectively address uterine diseases that impact women ́s health such as myomas or endometriosis and/or might contribute to infertility, infant and maternal mortality and morbidity.


HUTER technological and biological platform will be a crucial resource for the scientific and clinical communities to define the cellular basis of health and disease, allowing the rapid development of new diagnosis and prognosis tools and therapeutic advancements in the field.


Link to the project website: https://huter-hca.eu/